Dexamethasone
Allergic States, Dermatologic Diseases, Endocrine Disorders, Gastrointestinal Diseases, Hematologic Disorders, Neoplastic Diseases
Indications
- Allergic States
- Dermatologic Diseases
- Endocrine Disorders
- Gastrointestinal Diseases
- Hematologic Disorders
- Neoplastic Diseases
Adult dosing
- initial oral: dose: 0.75; unit: mg; route: PO; interval: 0.75 mg to 9 mg a day; fixed: true; labelExcerpt: The initial dosage varies from 0.75 mg to 9 mg a day depending on the disease being treated.
- multiple sclerosis: dose: 30; unit: mg; route: PO; interval: 30 mg daily for a week then 4 mg to 12 mg every other day; fixed: true; labelExcerpt: In the treatment of acute exacerbations of multiple sclerosis, daily doses of 30 mg of dexamethasone for a week followed by 4 mg to 12 mg every other day for one month have been shown to be effective
- cerebral edema: dose: 10; unit: mg; route: IV; interval: 10 mg initially followed by 4 mg every 6 hours; fixed: true; titrationTarget: Titrate to effect as symptoms subside; labelExcerpt: dexamethasone sodium phosphate injection is generally administered initially in a dosage of 10 mg intravenously followed by 4 mg every six hours intramuscularly until the symptoms of cerebral edema subside.
- brain tumor maintenance: dose: 2; unit: mg; route: PO; interval: 2 mg two or three times daily; fixed: true; labelExcerpt: maintenance therapy with either dexamethasone sodium phosphate injection or dexamethasone tablets in a dosage of 2 mg two or three times daily may be effective.
Pediatric dosing
- initial dosing: dose: 0.02; unit: mg/kg/day; route: PO; interval: 0.02 mg to 0.3 mg/kg/day in 3 or 4 divided doses; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: The range of initial doses is 0.02 mg to 0.3 mg/kg/day in three or four divided doses (0.6 mg to 9 mg/m 2 bsa/day).
- croup: dose: 0.6; unit: mg/kg; route: PO/IM; interval: single dose; 0.15 mg/kg also studied; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; guideline: Cochrane Review CD001955.pub5: Glucocorticoids for croup in children, 2023 (off-label); evidence: cochrane-croup-steroids
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Systemic fungal infections
- Hypersensitivity to components
Clinical pearls
- Monitor linear growth in pediatric patients.
- Gradually withdraw after long-term therapy.
- Monitor for infection as signs may be masked.
- Screen for hepatitis B before initiating immunosuppressive doses.
Source and review
- DailyMed label (dexamethasone), Set ID 12d19271-867b-41ae-a6d2-7e8de3637011, effective 2026-04-24; Cochrane Review CD001955.pub5: Glucocorticoids for croup in children, 2023 (off-label). Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties